SCHEMBL7094262

SCHEMBL7094262

COc1cccc(C(=NO)C2CCN(C(=O)O)CC2)c1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.47
KMT2A Q03164 4/20 0.47
LMNA P02545 2/20 0.47
MGLL Q99685 1/20 0.42
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPK14 Q16539 1/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.41
TSHR P16473 1/20 0.41
HTR2A P28223 1/20 0.41
GRM2 Q14416 1/20 0.41
HSD17B10 Q99714 1/20 0.40
ACHE P22303 1/20 0.40
BACE1 P56817 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 2/20 0.39
KAT6A Q92794 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2965823 0.86 STS (0.46) HSD11B1KMT2ALMNAALDH1A1MEN1
SCHEMBL2965825 0.86 STS (0.46) HSD11B1KMT2ALMNAALDH1A1MEN1
SCHEMBL7097807 0.85 HSD11B1 (0.57) HSD11B1KMT2ALMNAMGLLALDH1A1
SCHEMBL14637537 0.75 KMT2A (0.62) HSD11B1KMT2ALMNAMGLLCYP2C9
SCHEMBL4232496 0.74 HSD11B1 (0.64) HSD11B1KMT2ALMNAMGLLALDH1A1
SCHEMBL2956024 0.71 HSD11B1 (0.52) HSD11B1KMT2ALMNAMGLLALDH1A1
SCHEMBL2961719 0.70 EPHX2 (0.46) KMT2AMEN1
SCHEMBL2961720 0.70 EPHX2 (0.46) KMT2AMEN1
SCHEMBL13220728 0.70 STS (0.48) HSD11B1KMT2ALMNAALDH1A1MEN1
SCHEMBL352148 0.69 HTT (0.58) KMT2AALDH1A1GAATSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1361875-A2 NOVEL HETEROCYCLIC AMIDE DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS Aventis Pharmaceuticals Inc. (US) 2003-11-19 EP disclosed
WO-2002066469-A2 NOVEL HETEROCYCLIC AMIDE DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS AVENTIS PHARMACEUTICALS INC. (US) 2002-08-29 WO disclosed